Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals1 week agoClifford Chance advises on US$600 million green bond issuance by the City of BogotáRead MoreFacebookX.comPinterestLinkedinEmail39470
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals1 week agoClifford Chance advises the underwriters on Princes Group’s IPO and London listingRead MoreFacebookX.comPinterestLinkedinEmail39070
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals1 week agoClifford Chance advises Cesce on a landmark guarantee to the European Investment BankRead MoreFacebookX.comPinterestLinkedinEmail39370
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals1 week agoClifford Chance advises Bending Spoons in the latest investment roundRead MoreFacebookX.comPinterestLinkedinEmail39070
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals1 week agoClifford Chance advises Hillwood on the acquisition of two industrial and logistics parksRead MoreFacebookX.comPinterestLinkedinEmail39070
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals1 week agoClifford Chance advises Joyson Electronics on its IPO and listing in Hong KongRead MoreFacebookX.comPinterestLinkedinEmail39070
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals1 week agoLatham Represents Strategy in Inaugural Euro-Denominated Preferred Stock IPORead MoreFacebookX.comPinterestLinkedinEmail39470
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals1 week agoLatham & Watkins Advises on Halozyme Therapeutics’ Convertible Senior Notes Offerings Totaling US$1.3 BillionRead MoreFacebookX.comPinterestLinkedinEmail39070
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals1 week agoLatham & Watkins Represents Mattel in US$600 Million Senior Unsecured Notes OfferingRead MoreFacebookX.comPinterestLinkedinEmail39370
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteLegal DesireDeals1 week agoLatham & Watkins Advises 4D Molecular Therapeutics on US$100 Million Offering of Common Stock and Pre-Funded WarrantsRead MoreFacebookX.comPinterestLinkedinEmail39070
